4//SEC Filing
NxStage Medical, Inc. 4
Accession 0001209191-13-031425
CIK 0001333170operating
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 7:05 PM ET
Size
9.2 KB
Accession
0001209191-13-031425
Insider Transaction Report
Form 4
Shea Thomas
SVP Manufacturing Operations
Transactions
- Exercise/Conversion
Common Stock
2013-06-10$4.32/sh+5,000$21,600→ 25,071 total - Sale
Common Stock
2013-06-10$13.73/sh−5,000$68,629→ 20,071 total - Exercise/Conversion
Stock Option (Right to Buy)
2013-06-10−5,000→ 85,000 totalExercise: $4.32From: 2009-03-31Exp: 2015-03-30→ Common Stock (5,000 underlying)
Footnotes (3)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2013.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.58 to $13.84. The reporting person undertakes to provide to the issuer, any holder of the issuer's stock, or the SEC, upon request, full information regarding the number of shares sold at each separate price within the range described above.
- [F3]This stock option vests as to 25% of the underlying shares on March 31, 2009 and then in 36 equal monthly installments thereafter.
Documents
Issuer
NxStage Medical, Inc.
CIK 0001333170
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001333170
Filing Metadata
- Form type
- 4
- Filed
- Jun 9, 8:00 PM ET
- Accepted
- Jun 10, 7:05 PM ET
- Size
- 9.2 KB